3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Phase 1
1
Status
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
1004
Fluorouracil
800
Capecitabine
764
Gemcitabine
650
Leucovorin
559
Irinotecan
537
Bevacizumab
513
Radiotherapy
460
Cisplatin
440
Drug Therapy
298
Cetuximab
280
Surgical Procedures, Operative
229
Paclitaxel
228
S 1 (combination)
217
pembrolizumab
205
Docetaxel
199
130-nm albumin-bound paclitaxel
196
Nivolumab
193
sintilimab
191
Radiosurgery
190
lenvatinib
180
Folfox protocol
179
Sorafenib
178
Albumin-Bound Paclitaxel
173
apatinib
170
tislelizumab
161
camrelizumab
160
Neoadjuvant Therapy
158
Blood Specimen Collection
154
durvalumab
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
mitazalimab
×
Gastrointestinal
×
Clear all
NCT07199764
2026-03-06
IGNITE
University of Pennsylvania
Phase 2
Recruiting
100 enrolled
NCT07437287
2026-02-27
CROCOBIL
UNICANCER
Phase 2/3
Not yet recruiting
160 enrolled
NCT05650918
2023-10-12
REACtiVe-2
Erasmus Medical Center
Phase 1
Completed
22 enrolled